Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Journal of Biopharmaceutical Statistics|September 8, 2020
Enhancing clarity of clinical trial safety reports for data monitoring committeesSonia M Thomas, Kwanhye Jung, Hengrui Sun, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 7, 2009
No difference in the 24-hour interstitial fluid glucose profile with modulations to the glycemic index of the dietLouise M Aston, Roberta Laccetti, Adrian P Mander, et al.
Prehospital Emergency Care|March 10, 2018
Effect of Dial-Out Prefix Change on 9-1-1 Calls at a Large State UniversityJane H Brice, Matthew A Psioda, Renee Johnson, et al.
Drug Discovery Today|November 28, 2015
Assessment of cognitive safety in clinical drug developmentJonathan P Roiser, Pradeep J Nathan, Adrian P Mander, et al.
Pharmaceutical Statistics|June 17, 2014
Missing data sensitivity analysis for recurrent event data using controlled imputationOliver N Keene, James H Roger, Benjamin F Hartley, et al.
Clinical Trials (London, England)|December 21, 2019
Designing and evaluating dose-escalation studies made easy: The MoDEsT web appPhilip Pallmann, Fang Wan, Adrian P Mander, et al.
The British Journal of Nutrition|September 26, 2013
Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humansCelia G Walker, Lucy M Browning, Adrian P Mander, et al.
Respiratory Research|January 8, 2020
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysisBenjamin F Hartley, Neil C Barnes, Sally Lettis, et al.
Annals of the American Thoracic Society|March 11, 2014
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthmaLynn E Katz, Gerald J Gleich, Benjamin F Hartley, et al.
Statistics in Medicine|February 14, 2025
Using Win Odds to Improve Commit-to-Phase-3 Decision-Making in OncologyBenjamin F Hartley, Thomas Drury, Brian Di Pace, et al.
Pageof 13